Display options
Cite
Lukka H, Waldron T, Chin J, et al. High-intensity focused ultrasound for prostate cancer: a practice guideline. Can Urol Assoc J. 2010;4(4):232-6doi: 10.5489/cuaj.870.
Lukka, H., Waldron, T., Chin, J., Mayhew, L., Warde, P., Winquist, E., Rodrigues, G., & Shayegan, B. (2010). High-intensity focused ultrasound for prostate cancer: a practice guideline. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 4(4), 232-6. https://doi.org/10.5489/cuaj.870
Lukka, Himu, et al. "High-intensity focused ultrasound for prostate cancer: a practice guideline." Canadian Urological Association journal = Journal de l'Association des urologues du Canada vol. 4,4 (2010): 232-6. doi: https://doi.org/10.5489/cuaj.870
Lukka H, Waldron T, Chin J, Mayhew L, Warde P, Winquist E, Rodrigues G, Shayegan B. High-intensity focused ultrasound for prostate cancer: a practice guideline. Can Urol Assoc J. 2010 Aug;4(4):232-6. doi: 10.5489/cuaj.870. PMID: 20694096; PMCID: PMC2910764.
Copy Download .nbib Format: NLM
Share it on

Can Urol Assoc J. 2010 Aug;4(4):232-6. doi: 10.5489/cuaj.870.

High-intensity focused ultrasound for prostate cancer: a practice guideline.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Himu Lukka, Tricia Waldron, Joseph Chin, Linda Mayhew, Padraig Warde, Eric Winquist, George Rodrigues, Bobby Shayegan

Affiliations

  1. Juravinski Cancer Centre, McMaster University, Hamilton, ON;

PMID: 20694096 PMCID: PMC2910764 DOI: 10.5489/cuaj.870

Abstract

OBJECTIVE: The aim of this practice guideline was to develop evidence-based recommendations for clinicians on the use of high-intensity focused ultrasound (HIFU) in patients with localized prostate cancer.

METHODS: The guideline was developed using the methods of Cancer Care Ontario's Program in Evidence-Based Care (PEBC). The core methodology of the PEBC's guideline development process is systematic review. A comprehensive literature search was undertaken to identify high-quality studies, reviews and other practice guidelines on the use of HIFU in prostate cancer. The evidence formed the basis of the recommendations, which were reviewed and amended where necessary, by clinical experts in medical and radiation oncology and urology.

RESULTS: The literature review yielded limited evidence. No randomized controlled trials or meta-analyses comparing HIFU with currently accepted management approaches were identified. The body of evidence is primarily based on data from case series. Internal feedback was provided by the PEBC Genitourinary Disease Site Group membership and the Report Approval Panel. External peer review included targeted review by clinical experts specifically requested to comment on the guideline, and professional consultation through an online survey of health care professionals.

CONCLUSION: HIFU is currently not recommended as an alternative to accepted curative treatment approaches for localized prostate cancer.

References

  1. J Endourol. 2003 Oct;17(8):673-7 - PubMed
  2. BJU Int. 2006 Sep;98(3):537-9 - PubMed
  3. Eur Urol. 2008 Jun;53(6):1194-201 - PubMed
  4. BJU Int. 2006 Jan;97(1):56-61 - PubMed
  5. J Endourol. 2000 Aug;14(6):519-28 - PubMed
  6. Curr Urol Rep. 2003 Jun;4(3):248-52 - PubMed
  7. Cancer. 2010 Jan 15;116(2):323-30 - PubMed
  8. Urology. 1999 Aug;54(2):273-7 - PubMed
  9. Mol Urol. 2000 Fall;4(3):183-7;discussion 189 - PubMed
  10. J Clin Oncol. 1995 Feb;13(2):502-12 - PubMed
  11. Urology. 2004 Feb;63(2):297-300 - PubMed
  12. World J Urol. 2006 Nov;24(5):585-90 - PubMed
  13. Hinyokika Kiyo. 2005 Oct;51(10):651-8 - PubMed
  14. BJU Int. 2006 Oct;98(4):770-2 - PubMed
  15. World J Urol. 2008 Oct;26(5):481-5 - PubMed
  16. Eur Urol. 2008 Mar;53(3):547-53 - PubMed
  17. Eur Urol. 2009 Mar;55(3):640-7 - PubMed
  18. Urology. 2004 Apr;63(4):625-9 - PubMed
  19. Int J Urol. 2006 Mar;13(3):228-33 - PubMed
  20. Jpn J Clin Oncol. 2008 Mar;38(3):192-9 - PubMed
  21. Eur Urol. 2007 Feb;51(2):381-7 - PubMed
  22. Urology. 2008 Dec;72(6):1329-33; discussion 1333-4 - PubMed
  23. J Endourol. 2001 May;15(4):437-40; discussion 447-8 - PubMed
  24. Mol Urol. 2000 Fall;4(3):179-82 - PubMed
  25. Eur Urol. 2001 Aug;40(2):124-9 - PubMed
  26. J Urol. 2009 Jan;181(1):105-11; discussion 111-2 - PubMed
  27. Prostate Cancer Prostatic Dis. 2008;11(1):40-5 - PubMed
  28. J Endourol. 2000 Apr;14(3):293-9 - PubMed
  29. Prostate Cancer Prostatic Dis. 2006;9(4):439-43 - PubMed

Publication Types